Absolutely, but in an indirect way
GLP-1 Users for Weight Management represent a 31.8% share, driven by the widespread adoption of GLP-1 receptor agonists specifically for obesity and weight management, along with the corresponding demand for protein, hydration, and micronutrient support to mitigate side effects and maintain nutritional balance
Have you seen your best self
In 2022, 1 in 8 people in the world were living with obesity (BMI 30) [1]
Take 3-5 seconds to complete the injection rather than pushing quickly
The IVIS system was employed to observe lung metastasis in mice subjected to different treatments on Days 14 and 21, revealing that the ZFPG, ZFP + US, and ZFPG + US treatments could suppress prostate cancer metastasis to the lungs